References
- [EDTRS] Early Treatment Diabetic Retinopathy Study research group1985Photocoagulation for diabetic macular edema. Early Treatment Diabetic Retinopathy Study report number 1Arch Ophthalmol10317968062866759
- GibranSKKhanKJungkimS2007Optical coherence tomographic pattern may predict visual outcome after intravitreal triamcinolone for diabetic macular edemaOphthalmology114890417467527
- GilliesMCSutterFKSimpsonJM2006Intravitreal triamcinolone for refractory diabetic macular edema: two-year results of a double-masked, placebo-controlled, randomized clinical trialOphthalmology1131533816828501
- HaritoglouCKookDNeubauerA2006Intravitreal bevacizumab (Avastin) therapy for persistent diffuse diabetic macular edemaRetina26999100517151486
- KapinMAYanniJMBradyMT2003Inflammation-mediated retinal edema in the rabbit is inhibited by topical nepafenacInflammation272819114635785
- KeTLGraffGSpellmanJM2000Nepafenac, a unique nonsteroidal prodrug with potential utility in the treatment of trauma-induced ocular inflammation: II. In vitro bioactivation and permeation of external ocular barriersInflammation243718410850858
- KernTSMillerCMDuY2007Topical administration of nepafenac inhibits diabetes induced retinal microvascular disease and underlying abnormalities of retinal metabolism and physiologyDiabetes56373917259381
- MelethADAgronEChanCC2005Serum inflammatory markers in diabetic retinopathyInvest Ophthalmol Vis Sci46429530116249511
- PearsonPALevyB2005Intravitreal fluocinolone implant for diabetic macular edema: Two year resultsARVO Annual MeetingFt. Lauderdale, FLMay 1–5